Secreted frizzled-related protein 4 expression is positively associated with responsiveness to Cisplatin of ovarian cancer cell lines <it>in vitro</it> and with lower tumour grade in mucinous ovarian cancers
<p>Abstract</p> <p>Background</p> <p>Ovarian cancer is one of the most lethal malignancies in women, as it is frequently detected at an advanced stage, and cancers often become refractory to chemotherapy. Evidence suggests that dysregulation of pro-apoptotic genes plays...
Main Authors: | Saran Uttara, Arfuso Frank, Zeps Nikolajs, Dharmarajan Arunasalam |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-10-01
|
Series: | BMC Cell Biology |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2121/13/25 |
Similar Items
-
The Role of Hexokinase II in the Regulation of Glycolysis and Cisplatin Sensitivity in Ovarian Cancer
by: Han, Chae Young
Published: (2018) -
ROS-Induced SIRT2 Upregulation Contributes to Cisplatin Sensitivity in Ovarian Cancer
by: Wenyu Wang, et al.
Published: (2020-11-01) -
BRCA1 Expression is an Important Biomarker for Chemosensitivity: Suppression of BRCA1 Increases the Apoptosis via Up-regulation of p53 and p21 During Cisplatin Treatment in Ovarian Cancer Cells
by: Ikuo Konishi, et al.
Published: (2006-01-01) -
Tumour suppressor genes in chemotherapeutic drug response
by: Dulcie Lai, et al.
Published: (2012-04-01) -
Antiproliferative Effects of Selected Chemotherapeutics in Human Ovarian Cancer Cell Line A2780
by: Kateřina Caltová, et al.
Published: (2012-01-01)